15 Best Growth Stocks to Buy for the Next 5 Years
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
Amneal Pharmaceuticals Inc. (AMRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 10,735,977 | $89,967,487 | +1% | 1.61% |
| 2. | Citadel Investment Group Ken Griffin | 7,492,029 | $62,783,203 | -17% | 0.01% |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 3,808,561 | $31,915,741 | +4% | 1.27% |
| 4. | Blackbarn Capital Jonathan Carter | 2,881,654 | $24,148,261 | +2% | 1.54% |
| 5. | Millennium Management Israel Englander | 2,087,398 | $17,492,395 | +58% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.21 | 50,000 | $210,500.00 | 258,784 | 2021-12-17 | Filing | |
| $4.25 | 50,000 | $212,500.00 | 512,566 | 2021-12-16 | Filing | |
| $4.13 | 100,000 | $413,000.00 | 462,566 | 2021-12-15 | Filing | |
| $4.25 | 50,000 | $212,500.00 | 512,566 | 2021-12-16 | Filing | |
| $4.13 | 100,000 | $413,000.00 | 462,566 | 2021-12-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.02 | 94,906 | $761,146.12 | 1,609,144 | 2025-06-16 | Filing | |
| $8.02 | 56,426 | $452,536.52 | 1,704,050 | 2025-06-10 | Filing | |
| $7.58 | 49,140 | $372,481.20 | 388,929 | 2025-05-16 | Filing | |
| $7.59 | 50,000 | $379,500.00 | 257,433 | 2025-05-12 | Filing | |
| $8.00 | 4,900 | $39,200.00 | 1,720,218 | 2025-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,762,727 | $132,091,652 | 0% | |
| 2. | 12,587,778 | $105,485,581 | 0% | |
| 3. | 12,328,767 | $103,315,067 | 2.04% | |
| 4. | 5,103,156 | $42,761,001 | 0.01% | |
| 5. | 3,825,411 | $32,063,954 | 0% |
News See All
Amneal Pharmaceuticals Initiates Nationwide Recall of Contaminated Sulfamethoxazole/Trimethoprim Tablets
On June 1, Amneal Pharmaceuticals Inc. (NASDAQ:AMRX) initiated a nationwide recall of 3 specific lots of its Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg.
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2025 Earnings Call Transcript
Tony DiMeo: Good morning and thank you for joining Amneal Pharmaceuticals first quarter 2025 earnings call. Today, we issued a press release reporting Q1 results.
10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q4 2024 Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q4 2024 Earnings Call Transcript February 28, 2025Amneal Pharmaceuticals, Inc. misses on earnings expectations.
10 Best Weight Loss Drug Stocks to Buy According to Analysts
Most people have tried to include fitness and weight loss into their everyday routines.
12 Best Low Price Pharma Stocks To Invest In Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
10 Best Diabetes Stocks To Buy Under $10
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average.
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2024 Earnings Call Transcript
Operator: Hello, everyone and thank you for your patience. The Amneal Pharmaceuticals Third Quarter 2024 Earnings Call will begin shortly. [Operator Instructions] Thank you.
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2024 Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2024 Earnings Call Transcript August 9, 2024Amneal Pharmaceuticals, Inc. misses on earnings expectations.
Billionaire Hedge Funds
